For instance, miR-26a and miR-22 have been identified as potential regulators of CHD by targeting the PTEN gene, leading to Akt activation and contributing to complex CHD such as TOF and bicuspid aortic valve (BAV) [13–15]. The gene discussed is PTEN; the disease is coronary artery disorder.